(Q24202505)

6

0 references

Bianca Hemmingsen

1

object named as

Bianca Hemmingsen

0 references

Thomas Almdal

5

object named as

Thomas P Almdal

0 references

author name string

Søren S Lund

2

0 references

Allan Vaag

Cochrane Database of Systematic Reviews

4

0 references

publication date

11 November 2013

0 references

published in

0 references

cites work

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of medical therapies on retinopathy progression in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of combination lipid therapy in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Intensive multifactorial intervention improves modelled coronary heart disease risk in screen-detected Type 2 diabetes mellitus: a cluster randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

No negative effects of a multi-factorial, intensified treatment on self-reported health status, treatment satisfaction, and diabetes-related distress in screen-detected type 2 diabetes patients. The ADDITION-Netherlands study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Long-term multiple risk factor interventions in Japanese elderly diabetic patients: the Japanese Elderly Diabetes Intervention Trial--study design, baseline characteristics and effects of intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Factors associated with progression of diabetic nephropathy in Japanese elderly patients with type 2 diabetes: sub-analysis of the Japanese Elderly Diabetes Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The effects of intensive glycaemic control on body composition in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Randomized study of two different target levels of glycemic control within the acceptable range in type 2 diabetes. Effects on well-being at 1 year.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of intensified metabolic control on CNS function in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of improved metabolic control on platelet reactivity in patients with type 2 diabetes mellitus following coronary angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Evaluation of a pharmaceutical care model on diabetes management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of intravenous insulin administration on left ventricular performance during non-ST-elevation acute coronary events in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Intensive insulin treatment reduces transient ischaemic episodes during acute coronary events in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Observation on renal outcomes in the Veterans Affairs Diabetes Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Validation of the DeLiT Trial intravenous insulin infusion algorithm for intraoperative glucose control in noncardiac surgery: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Design and Organization of the Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT) Trial: a factorial trial evaluating the effects of corticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

A Single Blinded Randomized Controlled Study of the Effect of Conventional Oral Hypoglycemic Agents Versus Intensive Short-Term Insulin Therapy on Pure Tone Audiometry in Type II Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The Minnesota diabetes complications clinical trial the first three years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Treatment intensification in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Comparison of three protocols for tight glycemic control in cardiac surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

One-year efficacy and safety of the telehealth system in poorly controlled type 2 diabetic patients receiving insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of motivational interviewing intervention on self-management, psychological and glycemic outcomes in type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of an educational Inpatient Diabetes Management Program on medical resident knowledge and measures of glycemic control: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a r

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Can a protocol for glycaemic control improve type 2 diabetes outcomes after gastric bypass?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of moderate intensity glycemic control after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

An intensive nurse-led, multi-interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Piloting a novel algorithm for glucose control in the coronary care unit: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Randomised controlled trial of structured personal care of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Basal insulin and cardiovascular and other outcomes in dysglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

3-year follow-up of clinical and behavioral improvements following a multifaceted diabetes care intervention: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Rapid improvement of glycemic control in type 2 diabetes using weekly intensive multifactorial interventions: structured glucose monitoring, patient education, and adjustment of therapy-a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of short-term intensive insulin therapy on quality of life in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The response to short-term intensive insulin therapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Short-term intensive insulin therapy in newly diagnosed type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Improving glycaemic control self-efficacy and glycaemic control behaviour in Chinese patients with type 2 diabetes mellitus: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Clinical inertia in general practice: widespread and related to the outcome of diabetes care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Impact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Long-term effects of intensive glucose lowering on cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Economic costs of diabetes in the U.S. in 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Resurrections in Toronto: the emergence of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The barrier of hypoglycemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Methods for combining randomized clinical trials: strengths and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Uncertainty method improved on best-worst case analysis in a binary meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Bias in clinical intervention research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Hepatology may have problems with putative surrogate outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Sequential methods for random-effects meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Systematic review: glucose control and cardiovascular disease in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Insulin treatment and cardiovascular disease; friend or foe? A point of view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Overcoming the limitations of current meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Rosiglitazone for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Metformin monotherapy for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Estimating required information size by quantifying diversity in random-effects model meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

A Coefficient of Agreement for Nominal Scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: The Microalbuminuria Education and Medication Optimisation (MEMO) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

The role of strict metabolic control by insulin infusion on fibrinolytic profile during an acute coronary event in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulphonylurea failure: a 1-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Intensive versus conventional insulin therapy in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Diabetes Care Protocol: effects on patient-important outcomes. A cluster randomized, non-inferiority trial in primary care

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

The effects of a supplemental, theory-based physical activity counseling intervention for adults with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Effect of intravenous infusion of insulin in diabetics with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Insiders criticise FDA's decision not to withdraw rosiglitazone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. Results of the CHIPS Study ("Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo")

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Inflammatory and oxidative stress markers after intravenous insulin in percutaneous coronary intervention with stent in type 2 diabetes mellitus: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Determination of the glycemic threshold for the regression or prevention of diabetic microangiopathies, and the insulin injection regimen to establish strict glycemic control in NIDDM

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Induced basal normoglycemia and altered platelet aggregation in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Is intensive glycemic control worth the expense?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008143.PUB3

7 January 2021

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD008143.PUB2

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

12 January 2024

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD009008.PUB2

Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy

12 January 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Standards of medical care in diabetes--2013

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Diagnosis and Classification of Diabetes Mellitus

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Retinopathy progression in type 2 diabetes

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Industry sponsorship and research outcome

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Standards of medical care in diabetes--2008.

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Report of the expert committee on the diagnosis and classification of diabetes mellitus

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Enhanced glucose control for preventing and treating diabetic neuropathy

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Pioglitazone for type 2 diabetes mellitus

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD008143.PUB3

10.1002/14651858.CD008143.PUB3

9 February 2024

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24214280

1 reference

Consolidated OpenCitations Corpus – April 2017